Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001209191-22-051391

Director acquired 240,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Castelein Caley · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-09-26 Grant or award : show line 1 in the form +240,000 $12.50 $3,000,000 499,998 I
Loading xslF345X03/doc4.xml…